No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TuHURA Biosciences Advances in Cancer Immunotherapy Innovations
TuHURA Biosciences Expects to Complete Enrollment for REM-001 Study in Q4
TuHURA Biosciences Sees Cash Runway Into 2H25
TuHURA Biosciences Outlines Development Pathway for IFx-2.0
TuHURA Biosciences Outlines Development Pathway For Single Phase 3 Accelerated Approval Registration Trial
No Data
No Data